ephedrine

In 1887 Nagajoshi Nagai (1845-1929), a Japanese researcher working in Germany, isolated ephedrine as the active ingredient of ma huang but found the substance to be highly toxic. In the 1920s, Chinese pharmacologist Ko Kuei Chen (1898-1988) and American pharmacologist Carl F. Schmidt (1893-1965), working at Peking Union Medical College, isolated ephedrine again. Chen and Schmidt, working with much smaller doses than Nagai, demonstrated ephedrine's value in treating heart disease and asthma. By 1927 Eli Lilly & Co. was manufacturing ephedrine on a large scale.

• Lilly Syrup No. 110, Ephedrine Sulphate, 1932
• Lilly Inhalant No. 20, Ephedrine Compound, 1932
• Swan-Myers Ephedrine Inhalant No. 66, ca. 1940

(Courtesy National Museum of American History, Smithsonian Institution)

Source: NIH: Government information at NLM Web sites is in the public domain.

	此作品在美國屬於公有領域，因為其是由美國政府的官員或僱員，基於其個人公務目的製作的作品，參考美國法典第17篇第1章第105條。 注意︰本模板僅適用於美國聯邦政府的原創作品，不適用於任何美國州、屬地、聯邦個體、縣、市或任何次級政府的作品。本模板也不適用於1978年以後由美國郵政署出版的郵票圖案（參看美國版權局實踐綱領第313.6(C)(1)條）。也不適用於部分美國硬幣；參看美國鑄幣局使用條款。
此作品無已知的著作權限制，亦不受所有相關和鄰接的權利限制。

https://creativecommons.org/publicdomain/mark/1.0/PDMCreative Commons Public Domain Mark 1.0falsefalse